Nuo Therapeutics, Inc. SEC filings AURX

Nuo Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 8, 2005. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.

Nuo Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 6, 2026 Sep 30, 2026
8-K Current report
Results of operations
Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Jun 3, 2026 May 29, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Jan 26, 2026 Jan 21, 2026
8-K Current report
Shareholder vote results
Dec 17, 2025 Dec 16, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
DEFA14A Additional proxy material Oct 30, 2025 —
DEF 14A Proxy statement Oct 30, 2025 Dec 16, 2025
8-K Current report
Officer or director change, Other events
Oct 10, 2025 Oct 7, 2025
D Filing Aug 4, 2025 —
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Material agreement
May 15, 2025 May 14, 2025
EFFECT Filing May 12, 2025 —
S-3/A Form s-3/a May 9, 2025 —
CORRESP Letter to the SEC May 8, 2025 —
UPLOAD Letter from the SEC May 6, 2025 —
S-3 Shelf registration May 1, 2025 —
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
S-8 Employee stock plan registration Apr 10, 2025 —
10-K Annual report Apr 1, 2025 Dec 31, 2024
NT 10-K Form nt 10-k Apr 1, 2025 Dec 31, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
D Filing Sep 23, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Sep 19, 2024 Sep 18, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
8-K Current report
Auditor change
Jun 11, 2024 Jun 7, 2024
D Filing May 22, 2024 —
8-K Current report
Material agreement, Unregistered share sale
May 21, 2024 May 17, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-K Annual report Apr 19, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Apr 16, 2024 Apr 16, 2024
NT 10-K Form nt 10-k Apr 1, 2024 Dec 31, 2023
D Filing Dec 22, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Dec 20, 2023 Dec 18, 2023
10-Q Quarterly report Nov 20, 2023 Sep 30, 2023
NT 10-Q Form nt 10-q Nov 15, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
D Filing Aug 8, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Aug 3, 2023 Aug 1, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-K/A Amended annual report Apr 18, 2023 Dec 31, 2022
10-K Annual report Apr 17, 2023 Dec 31, 2022
NT 10-K Form nt 10-k Mar 31, 2023 Dec 31, 2022
8-K Current report
Shareholder vote results
Dec 5, 2022 Dec 2, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2021
DEFA14A Additional proxy material Oct 20, 2022 —
DEF 14A Proxy statement Oct 20, 2022 Dec 2, 2022
8-K Current report
Other events
Sep 30, 2022 Sep 29, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Aug 30, 2022 Aug 24, 2022
10-Q/A Amended quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Other events
Jun 28, 2022 Jun 23, 2022
D Filing May 19, 2022 —
10-Q Quarterly report May 16, 2022 Mar 31, 2022
D Filing May 6, 2022 —
8-K Current report
Material agreement, Unregistered share sale
May 2, 2022 Apr 29, 2022
DEF 14C Information statement Apr 27, 2022 Apr 27, 2022
10-K Annual report Apr 15, 2022 Dec 31, 2021
NT 10-K Form nt 10-k Mar 31, 2022 Dec 31, 2021
SC TO-T/A Final amendment Mar 21, 2022 —
SC 14D9 Schedule 14d9 Feb 4, 2022 —
SC TO-T Schedule to Jan 21, 2022 —
8-K Current report
Material agreement, Unregistered share sale
Jan 4, 2022 Dec 1, 2021
8-K Current report
Other events
Apr 21, 2021 Apr 20, 2021
8-K Current report
Material agreement, Unregistered share sale
Oct 6, 2020 Oct 5, 2020
8-K Current report
Other events
Apr 13, 2020 Apr 3, 2020
8-K Current report
Other events
Mar 30, 2020 Mar 30, 2020
10-Q Quarterly report Jan 31, 2020 Sep 30, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 12, 2019 Dec 6, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 20, 2019 Nov 15, 2019
NT 10-Q Form nt 10-q Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report Aug 19, 2019 Jun 30, 2019
NT 10-Q Form nt 10-q Aug 14, 2019 Jun 30, 2019
8-K Current report
Material agreement
Aug 9, 2019 Aug 6, 2019
8-K Current report
Material agreement
Jun 13, 2019 Jun 11, 2019
10-Q Quarterly report May 20, 2019 Mar 31, 2019
NT 10-Q Form nt 10-q May 15, 2019 Mar 31, 2019
8-K Current report
Material agreement
May 7, 2019 May 3, 2019
PRE 14A Preliminary proxy statement Apr 17, 2019 Apr 17, 2019
10-K Annual report Apr 16, 2019 Dec 31, 2018
NT 10-K Form nt 10-k Apr 1, 2019 Dec 31, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Mar 22, 2019 Mar 19, 2019
8-K Current report
Regulation FD disclosure
Jan 15, 2019 Jan 15, 2019
8-K Current report
Officer or director change
Jan 3, 2019 Dec 31, 2018
10-Q Quarterly report Nov 16, 2018 Sep 30, 2018
NT 10-Q Form nt 10-q Nov 14, 2018 Sep 30, 2018
8-K Current report
Material agreement
Oct 26, 2018 Oct 24, 2018
8-K Current report
Material agreement
Oct 2, 2018 Sep 28, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 21, 2018 Sep 17, 2018
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Sep 5, 2018 Sep 4, 2018
DEF 14A Proxy statement Aug 28, 2018 Sep 28, 2018
PRE 14A Preliminary proxy statement Aug 15, 2018 Aug 15, 2018
10-Q Quarterly report Aug 13, 2018 Jun 30, 2018
8-K Current report
Auditor change, Officer or director change
Aug 10, 2018 Aug 9, 2018
8-K Current report
Officer or director change
Jun 28, 2018 Jun 25, 2018
D Filing Jun 12, 2018 —
8-K Current report
Material agreement
May 30, 2018 May 28, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-K Annual report Apr 16, 2018 Dec 31, 2017
8-K Current report
Other events
Apr 4, 2018 Mar 29, 2018
NT 10-K Form nt 10-k Apr 2, 2018 Dec 31, 2017
8-K Current report
Officer or director change, Other events
Jan 19, 2018 Jan 12, 2018
PRE 14A Preliminary proxy statement Dec 13, 2017 Dec 12, 2017
10-Q Quarterly report Nov 13, 2017 Sep 30, 2017
8-K Current report
Auditor change
Sep 28, 2017 Sep 27, 2017
8-K Current report
Unregistered share sale, Other events
Sep 14, 2017 Sep 11, 2017
8-K Current report
Unregistered share sale, Other events
Aug 14, 2017 Aug 10, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
RW Form rw Aug 4, 2017 —
8-K Current report
Other events
Jul 5, 2017 Jul 5, 2017
S-1/A Amended registration statement Jun 30, 2017 —
S-1/A Amended registration statement Jun 21, 2017 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 12, 2017 Jun 9, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
8-K Current report
Shareholder vote results
May 8, 2017 May 5, 2017
DEF 14A Proxy statement Apr 28, 2017 Apr 28, 2017
PRE 14A Preliminary proxy statement Apr 17, 2017 Apr 17, 2017
S-1 Registration statement Apr 11, 2017 —
8-K Current report
Officer or director change
Apr 10, 2017 Apr 6, 2017
PRE 14C Form pre 14c Apr 3, 2017 Apr 3, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
8-K Current report
Regulation FD disclosure
Mar 6, 2017 Mar 6, 2017
8-K Current report
Regulation FD disclosure
Feb 1, 2017 Jan 31, 2017
8-K Current report
Regulation FD disclosure
Jan 20, 2017 Jan 20, 2017
424B3 Prospectus Jan 13, 2017 —
EFFECT Filing Jan 11, 2017 —
CORRESP Letter to the SEC Jan 9, 2017 —
CORRESP Letter to the SEC Dec 23, 2016 —
S-1/A Amended registration statement Dec 23, 2016 —
UPLOAD Letter from the SEC Dec 19, 2016 —
DEF 14C Information statement Nov 25, 2016 Nov 28, 2016
8-K Current report
Other events
Nov 22, 2016 Nov 21, 2016
S-1 Registration statement Nov 21, 2016 —
8-K Current report
Regulation FD disclosure
Nov 17, 2016 Nov 11, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report Oct 24, 2016 Jun 30, 2016
10-Q Quarterly report Oct 24, 2016 Mar 31, 2016
10-K Annual report Oct 24, 2016 Dec 31, 2015
8-K Current report
Regulation FD disclosure
Aug 24, 2016 Aug 22, 2016
NT 10-Q Form 12b-25 Aug 12, 2016 Jun 30, 2016
8-K Current report
Unregistered share sale, Other events
Aug 1, 2016 May 5, 2016
8-K Current report
Officer or director change, Other events
Jul 8, 2016 Jul 1, 2016
8-K Current report
Auditor change
Jun 16, 2016 Jun 15, 2016
8-K Current report
Auditor change
Jun 10, 2016 Jun 1, 2016
8-K Current report
Regulation FD disclosure
Jun 6, 2016 Jun 3, 2016
D Filing May 20, 2016 —
NT 10-Q Form 12b-25 May 17, 2016 Mar 31, 2016
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
May 10, 2016 May 5, 2016
8-A12G Filing May 10, 2016 —
8-K Current report
Bankruptcy
Apr 28, 2016 Apr 25, 2016
8-K Current report
Regulation FD disclosure
Apr 21, 2016 Apr 20, 2016
NT 10-K Form 12b-25 Mar 31, 2016 Dec 31, 2015
8-K Current report
Material agreement
Mar 31, 2016 Mar 22, 2016
8-K Current report
Regulation FD disclosure, Other events
Mar 30, 2016 Mar 27, 2016
8-K Current report
Regulation FD disclosure
Mar 22, 2016 Mar 21, 2016
8-K Current report
Material agreement, Bankruptcy
Mar 11, 2016 Mar 9, 2016
8-K Current report
Agreement ended, Bankruptcy
Feb 29, 2016 Feb 23, 2016
8-K Current report
Material agreement, Bankruptcy, Other events
Feb 1, 2016 Jan 26, 2016
8-K Current report
Officer or director change
Jan 12, 2016 Jan 12, 2016
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Jan 12, 2016 Jan 8, 2016
424B3 Prospectus Dec 23, 2015 —
8-K Current report
Material agreement, Other events
Dec 18, 2015 Dec 18, 2015
8-K Current report
Material agreement, Exit or restructuring costs
Dec 10, 2015 Dec 4, 2015
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
8-K Current report
Results of operations
Nov 13, 2015 Nov 12, 2015
8-K Current report
Material agreement
Oct 22, 2015 Oct 16, 2015
424B3 Prospectus Sep 1, 2015 —
10-Q Quarterly report Aug 13, 2015 Jun 30, 2015
8-K Current report
Results of operations
Aug 13, 2015 Aug 13, 2015
8-K Current report
Officer or director change
Jul 15, 2015 Jul 9, 2015
EFFECT Filing Jun 22, 2015 —
424B3 Prospectus Jun 3, 2015 —
424B3 Prospectus Jun 3, 2015 —
POS AM Filing Jun 3, 2015 —
10-Q Quarterly report May 14, 2015 Mar 31, 2015
8-K Current report
Results of operations
May 14, 2015 May 13, 2015
EFFECT Filing May 13, 2015 —
POS AM Filing May 13, 2015 —
POS AM Filing May 13, 2015 —
POS AM Filing May 5, 2015 —
8-K Current report
Officer or director change
Apr 30, 2015 Apr 24, 2015
10-K/A Amended annual report Apr 30, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2015 Dec 31, 2014
8-K Current report
Results of operations
Mar 31, 2015 Mar 31, 2015
8-K Current report
Material agreement, Other events
Jan 8, 2015 Jan 6, 2015
8-K Current report
Officer or director change
Dec 31, 2014 Dec 29, 2014
424B3 Prospectus Nov 20, 2014 —
424B3 Prospectus Nov 20, 2014 —
424B3 Prospectus Nov 20, 2014 —
424B3 Prospectus Nov 20, 2014 —
424B3 Prospectus Nov 20, 2014 —
8-K Current report
Bylaw or fiscal year change, Other events
Nov 17, 2014 Nov 12, 2014
10-Q Quarterly report Nov 13, 2014 Sep 30, 2014
DEF 14A Proxy statement Oct 1, 2014 Nov 12, 2014

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AURX (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1091596
Former names
Nuo Therapeutics, Inc (until Dec 23, 2014); CYTOMEDIX INC (until Oct 8, 2014); AUTOLOGOUS WOUND THERAPY INC (until Apr 10, 2000); AUTOLOGOUS WOUND TRERAPY INC (until Mar 23, 2000)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.